Procter & Gamble Manufactura S. de R.L. de C.V. was cited for contradictory drug listing information for Vicks Nyquil Severe Hot Remedy Cold and Flu Plus Congestion (NDC 58933-541), violating Section 510(j) of the FD&C Act and 21 CFR Part 207. The company submitted mismatched active ingredients between the product's labeling and the electronic listing file (SPL) submitted to FDA's Drug Registration and Listing System, with the active ingredients listed on the Drug Facts label not matching those in the electronic submission. Following an initial deficiency letter in October 2022 and a data removal notification in December 2022, the product's data was removed from FDA's Online NDC Directory due to the company's failure to correct these discrepancies.